Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology

Inclusion Criteria

• •1. All brain tumors with a favorable prognosis (median survival \> 10 year)
• •2. Age ≥ 18 years
• •3. ECOG performance status 0 - 1 / Karnofsky performance status 80 - 100
• •4. No - minimal neurocognitive impairment
• •5. Dosimetrical gain of protontherapy relative to photontherapy (≥5% on supratentorial brain dose or hippocampi)
• •6. Informed consent